Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProShares UltraShort Russell2000 (NY:TWM)

40.12 -1.07 (-2.60%)
Official Closing Price Updated: 4:10 PM EDT, Jul 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ProShares UltraShort Russell2000

3 Strategic ETFs for Bearish Investors Post-Election
Inverse leveraged ETFs targeting the S&P 500, the Russell 2000, and the MSCI Emerging Markets Index provide a well-rounded set of funds for bearish investors. 
Via MarketBeat
Topics ETFs Economy Government
Earnings Scheduled For November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter. 
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
Why Michael Burry Sees Long-Term Inflation, Bigger Market Crash Ahead
Scion Asset Management CEO Michael Burry took to Twitter Inc (NYSE: TWTR) on Tuesday to warn his 915,000 followers of long-term inflation and owes it to four critical factors. 
Via Benzinga
The Songs of the 50 States
A look at 50 ETFs after today's close. 
Via Talk Markets
Geopolitics: Near-Term Stock Market Risk Building
Russia just told the US to be ready for some 
Via Talk Markets
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.